Nanopore sequencing has emerged as a powerful tool in the study of central nervous system (CNS) research, particularly in understanding epigenetic modifications such as 5-methylcytosine (5mC) and 5-hydroxymethylcytosine (5hmC). A study by Halliwell utilized whole genomic DNA from mouse cerebellum to benchmark the detection capabilities of Oxford Nanopore Technologies against traditional sequencing methods. The research highlighted the effectiveness of nanopore sequencing in detecting these modifications, which are crucial for regulating gene expression and understanding neurological functions. The study also explored duplex base-calling, demonstrating its potential in studying strand asymmetric modifications, thus providing insights into the complexity of epigenetic regulation in CNS tissues (ref: Halliwell doi.org/10.1038/s42003-025-07681-0/). This advancement in sequencing technology not only enhances the sensitivity and specificity of detecting DNA modifications but also opens avenues for further research into the molecular underpinnings of CNS disorders. The implications of these findings suggest that nanopore sequencing could be pivotal in elucidating the role of epigenetic changes in neurodevelopmental and neurodegenerative diseases.